Process for the production of levetiracetam
Summary
USPTO granted Patent US12590059B2 to Suzhou BrightHope Pharmatech Co., Ltd. for a process to produce levetiracetam via crystallization in aqueous solution, resulting in a product containing no residual organic solvent. The patent lists 4 inventors (Songzhou Hu, Lijun Deng, Wen Yu, Zhen Song) and contains 13 claims under classification C07D 207/27.
What changed
USPTO issued Patent No. US12590059B2 to Suzhou BrightHope Pharmatech Co., Ltd. on March 31, 2026, covering a novel process for producing levetiracetam through crystallization in an aqueous solution, optionally with a water-soluble solvent. The process yields levetiracetam with no residual organic solvent. The application (No. 18210330) was filed on June 15, 2023, and the patent contains 13 claims classified under C07D 207/27.
Pharmaceutical manufacturers and generic drug producers should review this patent to ensure their levetiracetam production processes do not infringe on the granted claims. This is an informational patent grant conferring exclusivity rights to the assignee; no compliance actions or deadlines are triggered by this notice.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Process for the production of levetiracetam
Grant US12590059B2 Kind: B2 Mar 31, 2026
Assignee
SUZHOU BRIGHTHOPE PHARMATECH CO., LTD
Inventors
Songzhou Hu, Lijun Deng, Wen Yu, Zhen Song
Abstract
There is disclosed a process for the production of levetiracetam by crystallizing levetiracetam in an aqueous solution, optionally in the presence of a water-soluble solvent. The product of levetiracetam contains no residual organic solvent.
CPC Classifications
C07D 207/27
Filing Date
2023-06-15
Application No.
18210330
Claims
13
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.